Pearl River Capital, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Pearl River Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$40.39 - $56.73 $168,709 - $236,961	-4,177 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$51.77 - $66.18 $29,715 - $37,987	-574 Reduced 12.08%	4,177 $238,000
Q3 2020 Nov 13, 2020	BUY	$43.8 - $58.16 $208,093 - $276,318	4,751 New	4,751 $244,000
Q1 2019 May 02, 2019	SELL	$20.65 - $29.55 $2,705 - $3,871	-131 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$19.08 - $36.14 $2,499 - $4,734	131 New	131 $3,000

343K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.